Estabrook Capital Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Estabrook Capital Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$44
-99.9%
140.0%0.00%
Q3 2022$69,000
+19.0%
140.0%0.00%
Q2 2022$58,000
-28.4%
140.0%0.00%
Q1 2022$81,000
-22.9%
140.0%0.00%
Q4 2021$105,000
-16.7%
140.0%0.00%
Q3 2021$126,000
-25.0%
140.0%0.00%
Q2 2021$168,000
-4.0%
140.0%0.00%
Q1 2021$175,000
-19.7%
140.0%0.00%
Q4 2020$218,000
+65.2%
140.0%0.00%
Q3 2020$132,000
+5.6%
140.0%0.00%
Q2 2020$125,000
+40.4%
140.0%0.00%
Q1 2020$89,000
-23.9%
140.0%0.00%
Q4 2019$117,000140.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,032,980$12,950,0001.82%
EcoR1 Capital, LLC 2,308,079$14,702,0001.54%
Alexandria Capital, LLC 1,005,119$6,403,0001.05%
Casdin Capital, LLC 1,455,000$9,268,0000.98%
Rhenman & Partners Asset Management AB 700,000$4,459,0000.62%
Bellevue Group AG 3,850,000$24,525,0000.48%
GREAT POINT PARTNERS LLC 633,505$4,035,0000.42%
WASATCH ADVISORS LP 5,938,434$37,828,0000.39%
361 CAPITAL LLC 109,161$695,0000.32%
Ceeto Capital Group, LLC 50,000$319,0000.26%
View complete list of SANGAMO THERAPEUTICS INC shareholders